Current Medicinal Chemistry

This journal supports open access

Editor-in-Chief:

Atta-ur-Rahman, FRS
Honorary Life Fellow
Kings College
University of Cambridge
Cambridge
UK

Back

The Glutamatergic Neurotransmission in the Central Nervous System

Volume:19   Issue:9
Pp: 1269-1276
P. Marmiroli and G. Cavaletti
DOI: 10.2174/092986712799462711

Structure-Activity Relationships of Glutamate Carboxypeptidase II (GCPII) Inhibitors

Volume:19   Issue:9
Pp: 1282-1294
D. V. Ferraris, K. Shukla and T. Tsukamoto
DOI: 10.2174/092986712799462658

Glutamate and Multiple Sclerosis

Volume:19   Issue:9
Pp: 1295-1299
M. Frigo, M. G. Cogo, M. L. Fusco, M. Gardinetti and B. Frigeni
DOI: 10.2174/092986712799462559

Assessing Glutamatergic Function and Dysfunction in Peripheral Tissues

Volume:19   Issue:9
Pp: 1310-1315
L. Tremolizzo, G. Sala, C. P. Zoia and C. Ferrarese
DOI: 10.2174/092986712799462702

GCPII Variants, Paralogs and Orthologs

Volume:19   Issue:9
Pp: 1316-1322
K. Hlouchova, V. Navratil, J. Tykvart, P. Sacha and J. Konvalinka
DOI: 10.2174/092986712799462676

The Role of Glutamate Signaling in Pain Processes and its Regulation by GCP II Inhibition open access plus

Volume:19   Issue:9
Pp: 1323-1334
K. M. Wozniak, C. Rojas, Y. Wu Wu and B. S. Slusher
DOI: 10.2174/092986712799462630

Glutamate in CNS Neurodegeneration and Cognition and its Regulation by GCPII Inhibition open access plus

Volume:19   Issue:9
Pp: 1335-1345
K. A. Rahn, B. S. Slusher and A. I. Kaplin
DOI: 10.2174/092986712799462649

GCPII Imaging and Cancer

Volume:19   Issue:9
Pp: 1346-1359
C. A. Foss, R. C. Mease, S. Y. Cho, H. J. Kim and M. G. Pomper
DOI: 10.2174/092986712799462612

NAAG, NMDA Receptor and Psychosis

Volume:19   Issue:9
Pp: 1360-1364
Richard Bergeron and Joseph T. Coyle
DOI: 10.2174/092986712799462685

Recognition of Nucleic Acid Ligands by Toll-Like Receptors 7/8: Importance of Chemical Modification

Volume:19   Issue:9
Pp: 1365-1377
Hui Yu, Zhanli Wang, Gang Sun and Yongchun Yu
DOI: 10.2174/092986712799462603

Azole Antimycotics - A Highway to New Drugs or a Dead End?

Volume:19   Issue:9
Pp: 1378-1388
R. Musiol and W. Kowalczyk
DOI: 10.2174/092986712799462621

Non-Alcoholic Steatohepatitis: What Can We Learn from Animal Models?

Volume:19   Issue:9
Pp: 1389-1404
C. C. Almonacid-Urrego, S. Sanchez-Campos, M. J. Tunon and J. Gonzalez-Gallego
DOI: 10.2174/092986712799462586